New funding opportunity for functional genomics platforms to resolve multiple VUS in priority genes for Australian diagnostic laboratories and clinicians.
Projects will be eligible for catalyst funding up to $200,000.
For many disease genes there are significant numbers of potentially disease-causing variants which do not reach the current threshold for definitive genetic diagnosis. This can be burdensome for variant interpretation and clinical reporting, particularly for rare disease.
The Australian Functional Genomics Network (AFGN) invites expressions of interest to develop gene-specific functional genomics platforms to resolve multiple VUS in priority genes for Australian diagnostic labs and clinicians.
AFGN encourages researchers to utilise existing capabilities in their project design.